30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Thomas Ross

Track

Insider profile

Positions

Position Company Period
Executive Vice President - Global Sales MaxCyte Inc Jan. 1, 2014 - Jan. 1, 2016
Thomas Ross's trades of MaxCyte Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-08-05 2024-08-02
US MaxCyte Inc (MXCT)
PlS Planned sale
98,191 -38.3%
477.83
US$3,806,180 		98,191 -38.3% 477.83 US$3,806,180
2024-08-05 2024-08-01
US MaxCyte Inc (MXCT)
PlS Planned sale
87,152 -36.0%
31.35
US$1,850,801 		87,152 -36.0% 31.35 US$1,850,801
2024-07-10 2024-07-09
US MaxCyte Inc (MXCT)
PlS Planned sale
91,465 -21.4%
35.52
US$4,153,901 		91,465 -21.4% 35.52 US$4,153,901
2024-07-10 2024-07-08
US MaxCyte Inc (MXCT)
PlS Planned sale
19,802 -44.2%
4.03
US$79,782 		19,802 -44.2% 4.03 US$79,782
2024-06-24 2024-06-20
US MaxCyte Inc (MXCT)
PlS Planned sale
33,333 -57.1%
4.09
US$136,465 		33,333 -57.1% 4.09 US$136,465
2024-06-20 2024-06-20
US MaxCyte Inc (MXCT)
PrS Proposed sale
133,332
4.41
US$587,994 		133,332 4.41 US$587,994
2023-04-12 2023-04-12
US MaxCyte Inc (MXCT)
PlS Planned sale
5,583 -100.0%
5.00
US$27,915 		5,583 -100.0% 5.00 US$27,915
2023-04-12 2023-04-11
US MaxCyte Inc (MXCT)
PlS Planned sale
8,451 -100.0%
5.00
US$42,255 		8,451 -100.0% 5.00 US$42,255
2023-04-12 2023-04-10
US MaxCyte Inc (MXCT)
PlS Planned sale
100 -100.0%
5.00
US$500 		100 -100.0% 5.00 US$500
2023-04-07 2023-04-06
US MaxCyte Inc (MXCT)
PlS Planned sale
27,193 -100.0%
5.03
US$136,781 		27,193 -100.0% 5.03 US$136,781
2023-04-07 2023-04-05
US MaxCyte Inc (MXCT)
PlS Planned sale
6,967 -100.0%
5.00
US$34,835 		6,967 -100.0% 5.00 US$34,835
2023-04-04 2023-04-04
US MaxCyte Inc (MXCT)
PlS Planned sale
7,266 -100.0%
5.03
US$36,548 		7,266 -100.0% 5.03 US$36,548
2023-04-04 2023-04-03
US MaxCyte Inc (MXCT)
PlS Planned sale
100 -100.0%
5.01
US$501 		100 -100.0% 5.01 US$501
2023-04-04 2023-03-31
US MaxCyte Inc (MXCT)
PlS Planned sale
2,607 -100.0%
5.00
US$13,035 		2,607 -100.0% 5.00 US$13,035
2023-02-03 2023-02-02
US MaxCyte Inc (MXCT)
PlS Planned sale
11,575 -100.0%
5.77
US$66,788 		11,575 -100.0% 5.77 US$66,788
2023-02-03 2023-02-01
US MaxCyte Inc (MXCT)
PlS Planned sale
17,558 -100.0%
5.68
US$99,729 		17,558 -100.0% 5.68 US$99,729
2023-01-05 2023-01-05
US MaxCyte Inc (MXCT)
PlS Planned sale
9,467 -100.0%
5.04
US$47,714 		9,467 -100.0% 5.04 US$47,714
2023-01-05 2023-01-04
US MaxCyte Inc (MXCT)
PlS Planned sale
9,153 -100.0%
5.07
US$46,406 		9,153 -100.0% 5.07 US$46,406
2023-01-05 2023-01-03
US MaxCyte Inc (MXCT)
PlS Planned sale
10,513 -100.0%
5.13
US$53,932 		10,513 -100.0% 5.13 US$53,932
2022-12-06 2022-12-05
US MaxCyte Inc (MXCT)
PlS Planned sale
14,133 -100.0%
5.59
US$79,003 		14,133 -100.0% 5.59 US$79,003
2022-12-06 2022-12-02
US MaxCyte Inc (MXCT)
PlS Planned sale
15,000 -100.0%
6.02
US$90,300 		15,000 -100.0% 6.02 US$90,300
2022-11-03 2022-11-02
US MaxCyte Inc (MXCT)
PlS Planned sale
5,704 -100.0%
6.85
US$39,072 		5,704 -100.0% 6.85 US$39,072
2022-11-03 2022-11-01
US MaxCyte Inc (MXCT)
PlS Planned sale
23,429 -100.0%
6.94
US$162,597 		23,429 -100.0% 6.94 US$162,597
2022-10-12 2022-10-11
US MaxCyte Inc (MXCT)
PlS Planned sale
4,282 -100.0%
6.51
US$27,876 		4,282 -100.0% 6.51 US$27,876
2022-10-12 2022-10-10
US MaxCyte Inc (MXCT)
PlS Planned sale
24,851 -100.0%
6.45
US$160,289 		24,851 -100.0% 6.45 US$160,289
2021-11-16 2021-11-16
US MaxCyte Inc (MXCT)
S Sale
31,163 -100.0%
12.08
US$376,449 		31,163 -100.0% 12.08 US$376,449
2021-11-16 2021-11-15
US MaxCyte Inc (MXCT)
S Sale
51,352 -100.0%
12.16
US$624,440 		51,352 -100.0% 12.16 US$624,440
2021-11-16 2021-11-12
US MaxCyte Inc (MXCT)
S Sale
42,590 -100.0%
12.66
US$539,189 		42,590 -100.0% 12.66 US$539,189